September 15, 2020 -- Thermo Fisher Scientific is investing an additional $140 million to further expand its laboratory plastics consumables production to support the global need for COVID-19 testing, development, and manufacturing of therapies and vaccines.
The company will increase production of pipette and automation tips, storage tubes and plates, transfer pipettes, and packaging for vials and bottles. As a result, Thermo Fisher is creating more than 1,000 jobs across manufacturing sites globally, increasing automation capabilities, and optimizing warehouse sterilization capacity.